Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6: Prebiopsy MRI: Through the Looking Glass
- PMID: 32660749
- DOI: 10.1016/j.eururo.2020.06.005
Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6: Prebiopsy MRI: Through the Looking Glass
Comment in
-
Reply to Roderick C.N. van den Bergh, Olivier Rouvière, and Theodorus van der Kwast's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6. Prebiopsy MRI: Through the Looking Glass.Eur Urol. 2020 Sep;78(3):314-315. doi: 10.1016/j.eururo.2020.06.059. Epub 2020 Jul 4. Eur Urol. 2020. PMID: 32631742 No abstract available.
Comment on
-
Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence.Eur Urol. 2020 Sep;78(3):304-306. doi: 10.1016/j.eururo.2020.04.016. Epub 2020 May 7. Eur Urol. 2020. PMID: 32389443 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
